Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a global ...
Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise ...
Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the ...
Novotech, the award-winning Asia-Pacific CRO with 23 years of experience in the region, has further strengthened its ...
Frost & Sullivan today released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with ...